MetaSano

11/16/2025

Great news! A new study shows people with CKD can reduce — or even eliminate — the excess mortality risk normally linked to the disease.
With 6–7 risk factors under control, their risk becomes the same as people without CKD.
Only 1 in 100 patients reach that perfect zone today — but read the post and you’ll see it’s NOT difficult to lower your risk. Study link in the first comment.

11/13/2025

Did You Know Your Body Absorbs Phosphorus and Potassium Differently From Each Food?
Why the same nutrient can act very differently in your kidneys — and how food choices can change everything.

You can find the link in the first comment below!

11/10/2025

MetaSano has reached over 1,000 users!

What started as a simple idea — helping people with chronic kidney disease take control of their health through food — is now becoming a growing movement.

But that’s not all. We’ve just launched MetaSano IQ, our new platform designed to bring data intelligence and insights to kidney care — empowering patients, nutritionists, and researchers with meaningful information to slow disease progression and improve quality of life.

None of this would have been possible without the incredible support from our users, partners, and the community that believes, like we do, that food is the new medicine.

This is just the beginning — thank you for dreaming with us and helping us revolutionize kidney care!

11/09/2025

Our Sunday newsletter is out:
The Hidden Chain Reaction: How Other Chronic Conditions Are Fueling the Rise in Kidney Disease

https://ckdstage3.substack.com/p/the-hidden-chain-reaction-how-other

New global study reveals kidney disease is rising worldwide—driven by the growing epidemics of diabetes, obesity, and high blood pressure that together form a dangerous cycle of chronic illness.

11/05/2025

Our Wednesday newsletter is out

When kidneys age: exploring the link between kidney function and frailty

You can find the link in the first comment below!

11/02/2025

Our Sunday newsletter is themed: The Hidden Metabolic Signal That Predicts Kidney Risk
The link is in the first comment.

10/30/2025

Do you have IgA nephropathy and want to know about 10 medications currently being tested?
Even if your CKD has another cause, some of these drugs might help you too — several are designed to reduce proteinuria.
Our new newsletter is out — check the first comment for the link.

10/26/2025

Our Sunday newsletter is out
Everything You Need to Know About Drug Interactions
And why “medicine” doesn’t always mean “safe”
https://ckdstage3.substack.com/p/everything-you-need-to-know-about

And why “medicine” doesn’t always mean “safe”

10/23/2025

🧠 MetaSano IQ is here!
We’re excited to launch MetaSano IQ, an AI assistant built specifically for people with Chronic Kidney Disease (CKD). It’s trained on CKD research and clinical studies to help you:
Understand your lab results and what your doctor tells you
Ask better questions and get a second perspective
Make more informed decisions about your diet and lifestyle
Important: MetaSano IQ does not replace your doctor — it empowers you to be more informed and confident when discussing your health.
💧 Learn more and start exploring: https://metasanoiq.com

10/22/2025

The new Living With CKD Newsletter is out!
This edition introduces MetaSano IQ — the first AI trained on CKD science to deliver safe, evidence-based answers for people with chronic kidney disease.

https://ckdstage3.substack.com/p/why-you-should-be-cautious-trusting

MetaSano Launches the First AI Trained in Kidney Science to Deliver Safe, Accurate Answers for People with CKD

10/20/2025

Three essential tools to help you understand, track, and take control of your kidney and heart health.
https://ckdstage3.substack.com/p/the-3-most-important-calculators

Three essential tools to help you understand, track, and take control of your kidney and heart health.

10/15/2025

Check out our new newsletter featuring Denmark’s largest CKD study, covering almost the whole population.

https://ckdstage3.substack.com/p/what-the-new-danish-ckd-studies-tell

What we can learn from a country that studied nearly its entire population — and why your daily choices still make a difference